Skip to content

Efficacy, Safety and Recurrence After Cold-EMR Plus APC for Large Colonic Lesions

Prospective Observational Study APC AND BIOPSY POST COLD-EMR IN COLONIC LESIONS

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06435377
Acronym
EMR+APC
Enrollment
60
Registered
2024-05-30
Start date
2024-07-01
Completion date
2025-06-30
Last updated
2024-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonic Disease

Brief summary

This prospective observational study aims to evaluate the efficacy, safety and recurrence of cold-snaring for large colonic lesions combined with argon plasma coagulation of the resection bed.

Interventions

PROCEDUREProcedure: Cold EMR + APC

* Initial submucosal injection of saline solution and methylene blue, followed by 'piece-meal' resection using a dedicated cold snare * Biopsy of the resection bed * Ablation of the defect using argon plasma coagulation (APC).

Sponsors

Istituto Clinico Humanitas
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients aged ≧ 18 years undergoing colonoscopy for any indication (screening, anemia, surveillance, or scheduled to undergo endoscopic mucosal resection) * Lesions of 20 mm and larger. * All colonic lesions removed using COLD-EMR technique, presenting both adenomatous (Kudo IIIL/IIIS pit pattern) * Patients who were able to provide written informed consent

Exclusion criteria

* Suspected lesions for submucosal invasion (e.g., Kudo V or Paris 0-IIa-IIc with non-granular surface) * Lesions with a wide Paris 0-Is component (\>10mm) that could increase the risk of submucosal invasion and could limit the mechanical cutting of the snare * Pedunculated polyps * Active/quiescent colitis * Rectal lesions * Residual or recurrent adenoma after endoscopic mucosal resection

Design outcomes

Primary

MeasureTime frameDescription
Residual1 dayEvaluation of residual in the biopsy of the defect after the cold-EMR. The specimen will be evaluated independently from the polyp sample.
Recurrence1 yearThe recurrence rate of adenomas at the site of any qualifying, previously resected lesions is measured after 3-6 and 12 months.

Secondary

MeasureTime frameDescription
Rate of post-polipectomy syndrome1 dayThe post-polipectomy syndrome is defined by the presence of fever or abdominal pain
Efficacy of procedure1 dayComplete resection of polyp
Time1 dayAverage time of procedure and polyp resection time
perforation1 dayRate of perforation and delayed perforation
Rate of delayed bleeding of the patient1 dayDelayed-bleeding, defined was defined as clinical evidence of bleeding (hematemesis, hematochezia or melena or a decrease of hemoglobin concentration \> 2g/dL, which required transfusion or endoscopic reintervention with hemostasis within 30 days of hospital discharge)

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026